Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1993 Mar;68(3 Spec No):291–296. doi: 10.1136/adc.68.3_spec_no.291

Double blind trial of recombinant human erythropoietin in preterm infants.

A J Emmerson 1, H J Coles 1, C M Stern 1, T C Pearson 1
PMCID: PMC1590386  PMID: 8466265

Abstract

Twenty four infants between 27 and 33 weeks' gestation were recruited into a double blind study to investigate the use of recombinant human erythropoietin (r-HuEpo) for the prevention of anaemia of prematurity. Between 50 and 150 U of r-HuEpo (n = 16) or placebo was administered subcutaneously twice a week from 7 days of age until discharge. There was a significant increase in the reticulocyte count in infants receiving r-HuEpo sustained from the second week of treatment until discharge compared with placebo. There was a reduction in the number of transfusions required in the r-HuEpo group with only 47% requiring a transfusion compared with 87% in the placebo group. During treatment with r-HuEpo there was a significant rise in the red cell folate concentration, a significant fall in the ferritin concentration, and a significantly higher percentage of haemoglobin F at discharge suggesting active erythropoiesis. The study provides strong evidence for the efficacy of r-HuEpo in stimulating erythropoiesis and reducing the requirement for transfusions for anaemia of prematurity.

Full text

PDF
291

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown M. S., Garcia J. F., Phibbs R. H., Dallman P. R. Decreased response of plasma immunoreactive erythropoietin to "available oxygen" in anemia of prematurity. J Pediatr. 1984 Nov;105(5):793–798. doi: 10.1016/s0022-3476(84)80309-1. [DOI] [PubMed] [Google Scholar]
  2. Brown M. S., Phibbs R. H., Garcia J. F., Dallman P. R. Postnatal changes in erythropoietin levels in untransfused premature infants. J Pediatr. 1983 Oct;103(4):612–617. doi: 10.1016/s0022-3476(83)80600-3. [DOI] [PubMed] [Google Scholar]
  3. Cheron G., Bachoux I., Maier M., Massonneau M., Peltier J. Y., Girot R. Fetal hemoglobin in sudden infant death syndrome. N Engl J Med. 1989 Apr 13;320(15):1011–1012. doi: 10.1056/NEJM198904133201513. [DOI] [PubMed] [Google Scholar]
  4. Christensen R. D., Koenig J. M., Viskochil D. H., Rothstein G. Down-modulation of neutrophil production by erythropoietin in human hematopoietic clones. Blood. 1989 Aug 1;74(2):817–822. [PubMed] [Google Scholar]
  5. Emmerson A. J., Westwood N. B., Rackham R. A., Stern C. M., Pearson T. C. Erythropoietin responsive progenitors in anaemia of prematurity. Arch Dis Child. 1991 Jul;66(7 Spec No):810–811. doi: 10.1136/adc.66.7_spec_no.810. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Finne P. H. Erythropoietin levels in cord blood as an indicator of intrauterine hypoxia. Acta Paediatr Scand. 1966 Sep;55(5):478–489. doi: 10.1111/j.1651-2227.1966.tb15239.x. [DOI] [PubMed] [Google Scholar]
  7. GARBY L., SJOLIN S., VUILLE J. C. Studies on erythro-kinetics in infancy. II. The relative rate of synthesis of haemoglobin F and haemoglobin A during the first months of life. Acta Paediatr. 1962 May;51:245–254. doi: 10.1111/j.1651-2227.1962.tb06538.x. [DOI] [PubMed] [Google Scholar]
  8. Giulian G. G., Gilbert E. F., Moss R. L. Elevated fetal hemoglobin levels in sudden infant death syndrome. N Engl J Med. 1987 Apr 30;316(18):1122–1126. doi: 10.1056/NEJM198704303161804. [DOI] [PubMed] [Google Scholar]
  9. Halpérin D. S., Wacker P., Lacourt G., Félix M., Babel J. F., Aapro M., Wyss M. Effects of recombinant human erythropoietin in infants with the anemia of prematurity: a pilot study. J Pediatr. 1990 May;116(5):779–786. doi: 10.1016/s0022-3476(05)82671-x. [DOI] [PubMed] [Google Scholar]
  10. Hågå P., Meberg A., Halvorsen S. Plasma erythropoietin concentrations during the early anemia of prematurity. Acta Paediatr Scand. 1983 Nov;72(6):827–831. doi: 10.1111/j.1651-2227.1983.tb09824.x. [DOI] [PubMed] [Google Scholar]
  11. Jacobs K., Shoemaker C., Rudersdorf R., Neill S. D., Kaufman R. J., Mufson A., Seehra J., Jones S. S., Hewick R., Fritsch E. F. Isolation and characterization of genomic and cDNA clones of human erythropoietin. 1985 Feb 28-Mar 6Nature. 313(6005):806–810. doi: 10.1038/313806a0. [DOI] [PubMed] [Google Scholar]
  12. Keyes W. G., Donohue P. K., Spivak J. L., Jones M. D., Jr, Oski F. A. Assessing the need for transfusion of premature infants and role of hematocrit, clinical signs, and erythropoietin level. Pediatrics. 1989 Sep;84(3):412–417. [PubMed] [Google Scholar]
  13. Obladen M., Sachsenweger M., Stahnke M. Blood sampling in very low birth weight infants receiving different levels of intensive care. Eur J Pediatr. 1988 May;147(4):399–404. doi: 10.1007/BF00496419. [DOI] [PubMed] [Google Scholar]
  14. Phillips H. M., Holland B. M., Abdel-Moiz A., Fayed S., Jones J. G., Turner T. L., Wardrop C. A., Cockburn F. Determination of red-cell mass in assessment and management of anaemia in babies needing blood transfusion. Lancet. 1986 Apr 19;1(8486):882–884. doi: 10.1016/s0140-6736(86)90988-8. [DOI] [PubMed] [Google Scholar]
  15. Rhondeau S. M., Christensen R. D., Ross M. P., Rothstein G., Simmons M. A. Responsiveness to recombinant human erythropoietin of marrow erythroid progenitors from infants with the "anemia of prematurity". J Pediatr. 1988 Jun;112(6):935–940. doi: 10.1016/s0022-3476(88)80223-3. [DOI] [PubMed] [Google Scholar]
  16. Roberton N. R. Top up transfusions in neonates. Arch Dis Child. 1987 Oct;62(10):984–986. doi: 10.1136/adc.62.10.984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Saito T., Urabe A., Uramoto K., Hashimoto Y., Takaku F. Serum erythropoietin titres in the anaemia of premature infants. Br J Haematol. 1983 May;54(1):53–58. doi: 10.1111/j.1365-2141.1983.tb02066.x. [DOI] [PubMed] [Google Scholar]
  18. Sandler S. G., Grumet F. C. Posttransfusion cytomegalovirus infections. Pediatrics. 1982 May;69(5):650–653. [PubMed] [Google Scholar]
  19. Shannon K. M., Naylor G. S., Torkildson J. C., Clemons G. K., Schaffner V., Goldman S. L., Lewis K., Bryant P., Phibbs R. Circulating erythroid progenitors in the anemia of prematurity. N Engl J Med. 1987 Sep 17;317(12):728–733. doi: 10.1056/NEJM198709173171203. [DOI] [PubMed] [Google Scholar]
  20. Stockman J. A., 3rd, Garcia J. F., Oski F. A. The anemia of prematurity. Factors governing the erythropoietin response. N Engl J Med. 1977 Mar 24;296(12):647–650. doi: 10.1056/NEJM197703242961202. [DOI] [PubMed] [Google Scholar]
  21. Stockman J. A., 3rd, Graeber J. E., Clark D. A., McClellan K., Garcia J. F., Kavey R. E. Anemia of prematurity: determinants of the erythropoietin response. J Pediatr. 1984 Nov;105(5):786–792. doi: 10.1016/s0022-3476(84)80308-x. [DOI] [PubMed] [Google Scholar]
  22. Strauss R. G. Transfusion therapy in neonates. Am J Dis Child. 1991 Aug;145(8):904–911. doi: 10.1001/archpedi.1991.02160080082025. [DOI] [PubMed] [Google Scholar]
  23. Ward C. S., Westwood N. B., Emmerson A. J., Pearson T. C. The in vitro effect of high-dose recombinant human erythropoietin on granulocyte-macrophage colony production in premature infants using a defined serum deprived cell culture system. Br J Haematol. 1992 Jul;81(3):325–330. doi: 10.1111/j.1365-2141.1992.tb08235.x. [DOI] [PubMed] [Google Scholar]
  24. Wardrop C. A., Holland B. M., Veale K. E., Jones J. G., Gray O. P. Nonphysiological anaemia of prematurity. Arch Dis Child. 1978 Nov;53(11):855–860. doi: 10.1136/adc.53.11.855. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Zielke H. R., Meny R. G., O'Brien M. J., Smialek J. E., Kutlar F., Huisman T. H., Dover G. J. Normal fetal hemoglobin levels in the sudden infant death syndrome. N Engl J Med. 1989 Nov 16;321(20):1359–1364. doi: 10.1056/NEJM198911163212003. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES